Marc Frouin

Advisory Board Member

Marc Frouin

Marc has 30 years of experiences of entrepreneurship and R&D in High Technology and Medical Device. Including component design, electronics, micro-mechanics and complex integrated products. 7 years of experience of as investor including Angel and Venture capital. Marc has a special focus on early deployment made possible by advanced in micro-electronics and high technology to bring to market innovative solutions.

Marc leads currently the R&D and early market introduction of the pathology specific solutions of Bioserenity. Bioserenity is a French innovative company based in Paris largest hospital developing long term diagnostic and monitoring solutions for critical long term Pathologies in cardio, neuro, uro, maternity and sleep disorder. The solutions are based on second skin textile, flexible electronics, Cloud with IoT, data science and AI software. The company has a special focus on helping with diagnostics and monitoring that required long term measure for rare events like Epilepsy Seizures or cardio Arithmia.